Lanean...
Energy Regulation Mechanism and Therapeutic Potential of Asprosin
Genetic studies of patients with neonatal progeroid syndrome led to the discovery of the novel fasting-induced, glucogenic, and orexigenic hormone named asprosin, the C-terminal cleavage product of profibrillin. Upon secretion, asprosin travels to the liver, where it exerts a glucogenic effect throu...
Gorde:
| Argitaratua izan da: | Diabetes |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Diabetes Association
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7085243/ https://ncbi.nlm.nih.gov/pubmed/32198197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dbi19-0009 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|